PRINCIPI, MARIABEATRICE
 Distribuzione geografica
Continente #
NA - Nord America 7.607
EU - Europa 1.263
AS - Asia 580
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 3
SA - Sud America 1
Totale 9.466
Nazione #
US - Stati Uniti d'America 7.594
CN - Cina 498
SE - Svezia 430
IT - Italia 220
DE - Germania 191
GB - Regno Unito 100
FI - Finlandia 88
UA - Ucraina 66
BE - Belgio 48
FR - Francia 39
VN - Vietnam 27
RU - Federazione Russa 17
IN - India 16
RO - Romania 16
IE - Irlanda 15
SG - Singapore 15
GT - Guatemala 9
ES - Italia 8
NL - Olanda 8
AU - Australia 6
EU - Europa 5
HK - Hong Kong 5
KR - Corea 5
CA - Canada 3
JP - Giappone 3
MK - Macedonia 3
AL - Albania 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
PL - Polonia 1
SA - Arabia Saudita 1
SM - San Marino 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 9.466
Città #
Fairfield 1.284
Woodbridge 918
Chandler 689
Houston 589
Ashburn 548
Seattle 499
Cambridge 464
Wilmington 421
Ann Arbor 420
Nyköping 366
Jacksonville 220
Lawrence 133
Roxbury 130
Nanjing 125
Beijing 122
New York 113
Des Moines 78
Princeton 71
Bari 68
Inglewood 68
Dearborn 52
Brussels 47
San Diego 46
Brooklyn 36
Boardman 32
Dong Ket 26
Jiaxing 26
Shenyang 26
Hebei 24
Nanchang 24
Tianjin 24
Paris 19
Changsha 17
Dublin 15
Los Angeles 15
London 13
Redwood City 13
Falls Church 11
Pune 11
Guangzhou 10
Singapore 10
Guatemala City 9
Hefei 9
Jinan 9
Zhengzhou 9
Rome 8
Hangzhou 7
Kunming 7
Shanghai 7
Helsinki 6
Milan 6
Chicago 5
Hounslow 5
Kilburn 5
Mountain View 5
Munich 5
Norwalk 5
Orihuela Costa 5
San Jose 5
Washington 5
Wuhan 5
Edinburgh 4
Esslingen am Neckar 4
Hong Kong 4
Indiana 4
Ningbo 4
Triggiano 4
Bitetto 3
Böblingen 3
Florence 3
Frankfurt am Main 3
Leawood 3
Madrid 3
San Mateo 3
Sterling 3
Tappahannock 3
Tetovo 3
Toronto 3
Auburn Hills 2
Augusta 2
Brno 2
Calimera 2
Castellammare Di Stabia 2
Catania 2
Colle Brianza 2
Foggia 2
Frattamaggiore 2
Groningen 2
Lecce 2
Melbourne 2
Mumbai 2
Preganziol 2
Prescot 2
Pugliano 2
Redmond 2
San Francisco 2
Southwark 2
Sydney 2
Taizhou 2
Tokyo 2
Totale 8.051
Nome #
Assessment of Disease Activity in Small Bowel Crohn’s Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score 134
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 126
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 122
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 121
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 119
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 119
Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation 115
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 108
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 108
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 107
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 106
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 103
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 103
Endothelial function and cardiovascular risk in active inflammatory bowel diseases. 102
null 101
null 100
Oral Tacrolimus (FK-506) in Crohn' s disease complicated by fistulae of perineum 99
null 99
Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality? 95
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 95
A mysterious case of gastroparesis: could the secret be found in a drink? 94
null 93
Estrogens, phytoestrogens and colorectal neoproliferative lesions 91
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 91
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 90
Pattern of apoptosis in Crohn’s disease: a singular aspect? 89
null 89
null 88
Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study 87
null 86
null 86
Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study 86
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis 85
null 83
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 82
The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy 82
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 82
null 81
null 81
null 80
null 80
null 79
null 79
null 79
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 79
Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study 77
null 77
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 76
Alimentary disorders in young females with irritable bowel syndrome or ulcerative procto-sigmoiditis: A preliminary report. 75
null 74
Liver fibrosis in primary intestinal lymphangiectasia: an undervalued topic 73
null 73
null 73
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 73
The association between cardiac and gastrointestinal disorders: causal or casual link? 72
null 72
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness 72
null 71
null 70
null 70
null 70
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 70
null 69
null 69
null 68
null 67
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 67
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 67
null 65
Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis. 63
Probiotics and Helicobacter pylori 63
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes? 63
null 63
null 62
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 62
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease 60
Celiac disease and common variable immunodeficiency: a familial inheritance? 60
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 60
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 60
null 59
null 59
null 59
Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture 59
La gastrite cronica da Helicobacter Heilmannii: una nuova entità istopatologica. L’ infezione da Helicobacter pilori: aggiornamento continuo G Bianchi Porro, G Maconi, F Parente 58
null 58
Mucosal expression of Basic Fibroblastic Growth Factor, Syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies 58
Immunosuppressant supplementation to infliximab in Crohn's disease with extraintestinal involvement: A benefit in the long term? 58
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 58
null 57
null 55
null 55
Long-term tacrolimus: a promising therapeutic approach for Crohn’s disease 55
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study 54
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 53
Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (infliximab) treatment for Crohn disease: a case report 51
Seronegative celiac disease: where is the specific setting? 51
null 51
null 51
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 51
Lactobacillus reuteri strain combination in helicobacter pylori infection: A randomized, double-blind, placebo-controlled study 50
Totale 7.790
Categoria #
all - tutte 38.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.068 380 131 118 319 320 210 285 348 405 202 229 121
2020/20211.748 117 176 98 139 237 111 139 212 92 227 84 116
2021/20221.029 101 44 37 37 54 101 27 55 61 90 166 256
2022/20231.708 242 238 126 143 156 242 24 186 262 12 48 29
2023/2024571 36 107 23 55 53 164 14 23 6 27 13 50
2024/202523 23 0 0 0 0 0 0 0 0 0 0 0
Totale 10.022